The global digital PCR market was valued at $508.8 million in 2020, and is projected to reach $1,305.3 million by 2030, registering a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is defined as an approach for the detection & quantification of nucleic acids that provides a sensitive and reproducible way to measure the amount of DNA or RNA present in a sample. dPCR exhibits high potential in research (basic research and applied research), clinical diagnostics, forensics, and other similar areas. dPCR systems are useful for copy number variation, rare sequence detection, mutation detection, miRNA analysis, gene expression analysis, and next-generation sequencing sample quantification.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.
However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.
By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.
The global digital polymerase chain reaction market is expected to register substantial growth in the near future owing to rise in prevalence of infectious diseases and increase in awareness & acceptance of personalized medicines. For instance, according to World Health Organization (WHO), around 1.5 million people died from tuberculosis in 2020 across the globe. Droplet digital PCR (ddPCR) is one of the analysis tests to detect the presence of mycobacterium tuberculosis. In addition, advancements in the technology in healthcare sector are anticipated to boost the market growth during the forecast period.
However, high cost of dPCR devices and reimbursement issues are the factors anticipated to hamper the market growth during the forecast period. Conversely, surge in funding for R&D activities in medical devices sector is expected to offer remunerative opportunities for market players. The digital polymerase chain reaction market is segmented into technology, product type, application, end user, and region. By technology, the market is categorized into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR.
By product type, it is fragmented into digital PCR systems, consumables & reagents, and software & services. On the basis of application, it is segregated into research, clinical diagnostics, and forensic & others. As per end user, it is differentiated into pharmaceuticals & biotechnology industries, clinical diagnostic laboratories, and universities & other organizations. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players that operate in the global digital polymerase chain reaction market include Avance Biosciences, Bio-Rad Laboratories, Inc., Fluidigm Corporation, JN Medsys, Merck KGaA, PreciGenome LLC, Qiagen N.V, Stilla Technologies, Sysmex Corporation and Thermo Fisher Scientific, Inc.
Key Benefits For Stakeholders
- The report provides an in-depth analysis of the global digital PCR market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global digital PCR market growth.
Key Market Segments
BY TECHNOLOGY
- Droplet Digital Pcr
- Chip Based Digital Pcr
- Beaming Digital Pcr
BY PRODUCT TYPE
- igital Pcr Systems
- Consumables And Reagents
- Software And Services
BY APPLICATION
- Clinical Diagnostics
- Forensic And Others
- Research
BY END USER
- Pharmaceuticals And Biotechnology Industries
- Clinical Diagnostic Laboratories
- Universities And Other Organizations
BY REGION
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan, Republic Of China
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Key Market Players
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- STILLA TECHNOLOGIES
- sysmex corporation
- Thermo Fisher Scientific, Inc.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: DIGITAL PCR MARKET, BY TECHNOLOGY
CHAPTER 5: DIGITAL PCR MARKET, BY PRODUCT TYPE
CHAPTER 6: DIGITAL PCR MARKET, BY APPLICATION
CHAPTER 7: DIGITAL PCR MARKET, BY END USER
CHAPTER 8: DIGITAL PCR MARKET, BY REGION
CHAPTER 9: COMPANY LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Digital PCR Market,' the digital PCR market size was valued at $508.82 million in 2020, and is estimated to reach $1.3 Billion by 2030, growing at a CAGR of 8.6% from 2021 to 2030. Digital polymerase chain reaction (dPCR) is a laboratory method used to make many copies of very tiny amounts of the specific DNA from a sample. PCR allows these pieces of DNA to be amplified so that they can be detected. In addition, it is used for absolute quantification and analysis of minority sequences.Digital PCR enhances the sensitivity of real-time PCR and detects rare events such as single nucleotide mutations in a population of wild type sequences. With dPCR, a sample is partitioned so that individual nucleic acid molecules within the sample are localized and concentrated within many separate regions. After PCR amplification, nucleic acids may be quantified by counting the regions that contain PCR end product and positive reactions. PCR may be used to look for certain changes in a gene or chromosome, which may help find and diagnose a genetic condition or a disease, such as cancer. It may also be used to look at pieces of the DNA of certain bacteria, viruses, or other microorganisms to help diagnose an infection.
Depending on technology, the market is fragmented into droplet digital PCR (ddPCR), chip based digital PCR, and BEAMing digital PCR. The ddPCR segment was the major revenue contributor in 2020, owing to the fact that ddPCR technique provides a precise measure of DNA molecules through each drop. In addition, massive sample partitioning is a key aspect of the droplet digital PCR technique, which increases the demand. On the other side, demand for chip based digital PCR has also increased day by day, as it reduces the risk of cross contamination, which is further anticipated to boost the digital PCR market growth.
On the basis of product type, the market is categorized into digital PCR systems, consumables & reagents, and software & services. The software & services segment is projected to exhibit the fastest growth during the forecast period, as the software helps improve the efficiency of management of digital PCR data. Thus, there is an increase in the demand for these products, thereby propelling the digital PCR market trends.
The COVID-19 outbreak is anticipated to have a positive impact on the growth of the digital PCR market size as digital PCR tests are used for diagnosis of COVID-19 infection. The rise in prevalence of COVID-19 infection boosts the growth of market. For instance, according to world health organization (WHO) report, as of 19 December 2021, over 273 million cases and over 5.3 million deaths have been reported globally. In addition, increase in number of dedicated COVID-19 diagnostic centers further contributes in growth of digital PCR industry.
KEY FINDINGS OF STUDY
- On the basis of technology, the droplet digital PCR segment was the highest contributor to the digital PCR market share in 2020.
- Based on product type, digital PCR systems segment dominates the market in 2020
- Depending on application, clinical diagnostics segment was the highest contributor to the market in 2020.
- By end user, pharmaceuticals & biotechnology industries segment dominates the market in 2020.
- Region wise, North America garnered the largest revenue share in 2020, whereas Asia is anticipated to grow at the highest CAGR during the forecast period.
Companies Mentioned
- Avance Biosciences
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- STILLA TECHNOLOGIES
- sysmex corporation
- Thermo Fisher Scientific, Inc.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 210 |
| Published | March 2022 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 572.02 million |
| Forecasted Market Value ( USD | $ 1305.3 million |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
